Introduction {#s1}
============

It is hypothesized that the deficits in social cognition and related cognitive functions in Autism results from reduced synchronization between these key brain regions during different social and emotional tasks: recent research suggests autism to be a 'neural connectivity disorder'.

These interconnected neural systems can be understood through the relationship between functionally relevant anatomic areas and neurochemical pathways, the programming of which is genetically modulated during neurodevelopment and mediated through a range of neuropeptides and interacting neurotransmitter systems. It has been suggested that autism emerges from a developmental cascade in which a fundamental deficit in attention to social stimuli beginning as early as infancy leads to impaired interactions with primary caregivers. This results in abnormal development of social cognition, which in turn adversely affects later behavioral and functional domains such as language development which are dependent on these early processes.

A common neuroanatomical theme in autism is over-connectivity in closely related areas and decreased connectivity in longer circuitry needing large scale integration. Disordered development of grey and white matter in autistic individuals has been demonstrated in the frontal and temporal cortices, where selective increase in late developing white matter and narrow mini columns in frontal and temporal cortex has been associated with early accelerated postnatal head growth.^[@R1]^Studies have found fewer, abnormally small and densely packed neurons especially in lateral nucleus of the thalamus and the Purkinje cells of the cerebellum.^[@R2]^ The corpus callosum and major inter-hemispheric connection tracts are smaller than non-autistic, age- and gender-matched individuals.

Social brain network in autism {#s2}
==============================

Neuropsychiatric and neuropsychological evaluations in Autism have revealed selective dysfunction of 'social cognition', with sparing of motor, perceptual and basic cognitive skills. Social cognition includes a range of skills and functions required for successful interpersonal interaction, mediated by a 'Social Brain Network', consisting brain regions that are dysfunctional in autism: Fusiform face area (perception of personal identity), inferior frontal gyrus (facial expression imitation), posterior superior temporal sulcus (perception of facial expressions and eye gaze tasks), superior frontal gyrus (theory of mind, i.e., taking another person's perspective) and the amygdala (emotion processing).^[@R3]-[@R5]^

Theory of mind in autism {#s3}
========================

One theory of autism proposes that the core deficit is an inability to metalize and infer the state of mind of another person, or "Theory of Mind" (TOM).^[@R6]^ Autistic individuals perform poorly on typical ToM tasks, which involve guessing what a character is thinking based on a vignette presented in words or pictorially. Difficulty in metalizing leads to being unable to share or express emotions as they cannot anticipate thoughts and actions of others or even understand that others have their own intentions, feelings and points of view is been inferred from the study. Communication is a way of influencing others to construct a picture of the world similar to ones own, but in autism, individuals cannot conceive that others have inner worlds. They can master complex technical operations but cannot learn from verbal instructions and environmental clues, act on hints or understand humor or irony.

ToM deficits in autism have been linked to abnormal patterns of hypo activation in superior temporal gyrus, superior temporal sulcus, and basal temporal areas and hyper activation in Brodmann's area 9/10, compared to healthy subjects who perfor­med well on ToM tasks. Furthermore, it has been demonstrated that the amygdala and left medial prefrontal cortex, which are core regions in healthy subjects were not invol­ved at all in autistic subjects.^[@R7]^ While reduced amygdala and medial PFC function has also been associated with difficulty in attributing emotional states to others.^[@R8]^

Mirror neuron system in autism {#s4}
==============================

The Mirror Neuron System, which is postulated to underlie the ability to mimic, learn and understand the actions of others ^[@R9]^ has also been implicated in autism.^[@R10]^ Mirror neurons are those in the ventral motor regions that fire when subjects observe actions performed by con-specifics, particularly when the subject has to mimic or learn that action. Although mirror neuron dysfunction has been proposed in autism behavioral paradigms, but has not revealed differences between autistic and non-autistic children in imitating and understanding hand gestures.^[@R11]^ It has been proposed that lack of empathy, or the difficulty to 'feel what you feel' is linked to mirror neuron system dysfunction, but the evidence is sparse.

Genetic factors in autism {#s5}
=========================

The programming of various brain networks is genetically modulated during neurodevelopment and mediated through a range of neuropeptides and interacting neurotransmitter systems. Studies have reported that there are approximately 103 disease genes, 44 genomic loci are associated with autism.^[@R12]^ A recent review of genetic studies of autism identified three basic phenotype/genotype combinations:^[@R13]^

-   Autism plus phenotype consisting of Autism Spectrum Disorders (ASD) caused by rare, single-gene mutations; for e.g., fragile X in 5-10% in Autism Plus.

-   Broad autism phenotype caused by genetic variations in single or multiple genes. These variations are common and are present in the general population, but result in varying clinical phenotypes when they cross a certain threshold through complex gene-gene and gene-environment interactions.

-   A severe and specific phenotype caused by 'de-novo' mutations in the patient or transmitted through asymptomatic carriers of such mutation.

###### Disease genes and genetic disorders reported in individual with ASD

  Gene      Locus            Mutations/CNVs         Encoded protein/gene function                                                                                                                                                                                              Clinical features                                                                                         References
  --------- ---------------- ---------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------- -------------------------
  NTNG1     1p13.3           mutations              Protein acting as axon guidance cues during nervous system development                                                                                                                                                     Schizophrenia, ASDs                                                                                       ([@R14])
  CLCN6     1p36.22          mutations              Member of voltage-dependent chloride channel in the nervous system                                                                                                                                                         ASDs                                                                                                      ([@R15])
  NRXN1     2p16.3           mutations, CNVs        Cell adhesion molecule and a receptor in the nervous system, formation and maintenance of synaptic junctions                                                                                                               ASDs, schizophrenia, epilepsy, ADHD, ID, speech delay, hyperactivity, depression, learning difficulties   ([@R16]-[@R20])
  TBR1      2q24.2           mutations              Transcription factor required for normal brain development                                                                                                                                                                 Schizophrenia, ASDs                                                                                       ([@R21])
  SCN2A     2q24.3           mutations              Sodium channel, voltage-gated, type II, alpha subunit                                                                                                                                                                      ASDs epilepsy                                                                                             ([@R22], [@R23])
  SCN1A     2q24.3           mutations              Sodium channel, voltage-gated, type I, alpha subunit                                                                                                                                                                       ASDs epilepsy                                                                                             ([@R12], [@R24])
  CNTN4     3p32.2           mutations              Axonal-associated cell adhesion molecule                                                                                                                                                                                   ASDs                                                                                                      ([@R25])
  FOXP1     3p13             mutations              Transcription factor                                                                                                                                                                                                       ID, ASDs                                                                                                  ([@R12], [@R24])
  TBL1XR1   3q26.32          mutations              Transcription activation                                                                                                                                                                                                   ASDs                                                                                                      ([@R21])
  CDH10     5p14.2           mutations              Neuronal cell-adhesion molecule                                                                                                                                                                                            ASDs                                                                                                      ([@R26])
  CDH9      5p14.1           mutations              Neuronal cell-adhesion molecule                                                                                                                                                                                            ASDs                                                                                                      ([@R26])
  SLIT3     5q34q35.1        mutations              Axonal guidance regulator                                                                                                                                                                                                  Depression, schizophrenia, ASDs                                                                           ([@R21])
  SYNGAP1   6p21.32          mutations, CNVs        Development of cognition and proper synapse function                                                                                                                                                                       ID, ASDs                                                                                                  ([@R27])
  AHI1      6q23.3           mutations              Cerebellar and cortical development in humans                                                                                                                                                                              Joubert syndrome                                                                                          ([@R12], [@R25])
  HOXA1     7p15.3           mutations              Transcription factor                                                                                                                                                                                                       ASDs                                                                                                      ([@R12])
  RELN      7q22.1           deletions              Cell positioning and neuronal migration during brain development                                                                                                                                                           ASDs                                                                                                      ([@R28])
  CNTNAP2   7q36.1           mutations, CNVs        Cell adhesion molecule and receptor in the nervous system                                                                                                                                                                  Focal cortical dysplasia, ASDs, ID, epilepsy, schizophrenia, bipolar disorder                             ([@R12])
  DLGAP2    8p23.3           CNVs                   Molecular organization of synapses and neuronal cell signaling                                                                                                                                                             ASDs                                                                                                      ([@R27])
  CHD7      8q12.2           mutations, deletions   Chromatin remodeling                                                                                                                                                                                                       CHARGE syndrome, ASDs                                                                                     ([@R12])
  RIPK2     8q21.3           mutations              Interacts with p38 kinase                                                                                                                                                                                                  ASDs                                                                                                      ([@R15])
  UNC13B    9p13.3           mutations              Synaptic vesicle maturation in a subset of excitatory/glutamatergic synapses                                                                                                                                               ASDs                                                                                                      ([@R15])
  ABCA1     9q31.1           mutations              Neuronal structure and function                                                                                                                                                                                            Bipolar disorder, schizophrenia, ASDs                                                                     ([@R15])
  LAMC3     9q34.12          mutations              Laminin, plays a role in forming the con-volution of the cerebral cortex                                                                                                                                                   ASDs, ID                                                                                                  ([@R24])
  TSC1      9q34.13          mutations              Regulation of protein synthesis in a wide range of cell types including neurons                                                                                                                                            Tuberous sclerosis, ASDs                                                                                  ([@R29])
  ANK3      10q21.2          mutations              Protein that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton                                                                                                                             Bipolar disorder, ASDs                                                                                    ([@R15])
  PTEN      10q23.3          mutations              Modulating cell cycle, inhibition of the AKT signaling pathway                                                                                                                                                             Cowden syndrome, ASDs, macro-cephaly                                                                      ([@R25], [@R30]-[@R32])
  DHCR7     11q13.2          mutations              7-Dehydrocholesterol Reductase                                                                                                                                                                                             Smith-Lemli-Opitz syndrome, ASDs                                                                          ([@R12], [@R33])
            q13.5                                                                                                                                                                                                                                                                                                                                                                        
  SHANK2    11q13.3          mutations, deletions   Structural and functional organization of the dendritic spine and synaptic junction                                                                                                                                        Schizophrenia, ASDs, ID                                                                                   ([@R34])
  HTR3A     11q23.2          mutations              5-hydroxytryptamine (serotonin) receptor 3A                                                                                                                                                                                ASDs                                                                                                      ([@R24])
  GRIN2B    12p13.1          mutations              Glutamate receptor ionotropic, NMDA 2B                                                                                                                                                                                     ASDs, ADHD, schizophrenia                                                                                 ([@R21], [@R24])
  CACNA1C   12p13.3          mutations              Calcium channel, voltage-dependent, L type, alpha 1C subunit                                                                                                                                                               Timothy syndrome, ASDs                                                                                    ([@R12], [@R25])
  CHD8      14q11.2          mutations              Chromatin remodeling                                                                                                                                                                                                       ASDs, macrocephaly                                                                                        ([@R21], [@R22])
  TSC2      16p13.3          mutations              Regulation of protein synthesis in a wide range of cell types including neurons                                                                                                                                            Tuberous sclerosis                                                                                        ([@R25], [@R29])
  NF1       17q11.2          mutations              Stimulates the GTPase activity of Ras signaling pathway                                                                                                                                                                    Neurofibromatosis, ASDs                                                                                   ([@R12])
  KATNAL2   18q21.1          mutations              Microtubule-severing ATPase activity                                                                                                                                                                                       ASDs                                                                                                      ([@R22], [@R23])
  DYRK1A    21q22.13         mutations, CNVs        Plays a role in a signaling pathway regulating cell proliferation                                                                                                                                                          Majority of phenotypic features in down syndrome, ASDs, ID, microcephaly                                  ([@R21], [@R35])
  SHANK3    22q13.33         mutations, deletions   Structural and functional organization of the dendritic spine and synaptic junction                                                                                                                                        Phelan-McDermid syndrome, ASDs, schizophrenia                                                             ([@R29], [@R36]-[@R38])
  PTCHD1    Xp22.11          mutations, CNVs        Synaptic functioning                                                                                                                                                                                                       ASDs, ID                                                                                                  ([@R27], [@R39])
  NLGN4     Xp22.31 p22.32   mutations, CNVs        Neuronal cell surface protein involved in the formation and remodeling of central nervous system synapses                                                                                                                  ASDs, ID                                                                                                  ([@R28], [@R40]-[@R42])
  PHF8      Xp11.22          mutations              Cell cycle progression, rDNA transcription and brain development                                                                                                                                                           ASDs, ID                                                                                                  ([@R43])
  HUWE1     Xp11.22          mutations              Neural differentiation and proliferation                                                                                                                                                                                   ASDs, ID                                                                                                  ([@R43])
  NLGN3     Xq13.1           mutations, CNVs        Neuronal cell surface protein, involved in the formation and function of synapses                                                                                                                                          ASDs, ID                                                                                                  ([@R28], [@R29])
  FMR1      Xq27.3           mutations              Translation repressor                                                                                                                                                                                                      Fragile X syndrome, ID, ASDs                                                                              ([@R25], [@R32])
  MECP2     Xq28             mutations, CNVs        Chromosomal protein that binds to methylated DNA, neuron maturation, negative regulation of neuron apoptotic process, cerebellum development, regulation of postsynaptic membrane potential, regulation of transcription   Re& syndrome, ASDs, ID                                                                                    ([@R25], [@R32])
  SLC6A8    Xq28             mutations              Creatine transporter                                                                                                                                                                                                       Creatine deficiency syndrome, ID, ASDs                                                                    ([@R12])
  TMLHE     Xq28             mutations              Enzyme in the carnitine biosynthesis pathway                                                                                                                                                                               ASDs                                                                                                      ([@R43], [@R44])

When is a gene mutation pathogenic {#s6}
==================================

For a mutation to be pathogenic in autism, it should involve neurodevelopmental genes that regulate neuronal development, migration, circuitry formation and synapse function. Some candidate molecules are NGLs (neuronal cell adhesion molecules) NRX/CBLN/GIuD2 complex (synapse organizer), LRRs (transmembrane proteins), SHANK3 (multiple ankyrin repeat domains), which are all involved in synaptogenesis. This is mediated via signaling molecular pathways through ubiquitin, mammalian target of rapamycin(mTOR), kinase and adenosine phosphorylation pathway. Mutation of genes leads to cascade of events linking transcription (e.g. MECP2 transcriptional regulator), translation (fragile X mental retardation related protein FMRP; translational regulator) and specific synaptic proteins important for maintenance of excitation/inhibition (E/I) ratio during synapse formation. The disruption of E/l ratio results in alternated in a) structure of synaptic connections, b) molecular assembly of synapses c) functional synaptogenesis.^[@R45]^ E/I ratio imbalance also leads to high glutamatergic& low GABAergic activity and shift to excitatory hyper transmission states, leading to the development of a circuit which is hyperexcitable; i.e., a non-tunable circuit with poor differentiation and stability. ([Fig 1](#fig_1){ref-type="fig"}.)^[@R46]^

![Proteins with genetic variants associated with autism spectrum disorder (ASD) (excluding those in white ovals) are clustered in specific intracellular processes. In colour, proteins with genetic variants associated with ASD; in white, proteins not directly associated with ASD. From Ghosh et al., Nat Rev Drug Discov. 2013;12(10):777-90. Reprinted with permission.](ANS0972-7531-21-69-g001){#fig_1}

Mutations of genes regulating neuronal migration may result in abnormal organization of cortical mini-columns and poor synchronization between neural regions, such as the hippocampus and prefrontal cortex, which is fundamental for learning and memory.^[@R47]^

Conceptual framework for autism: from behavior to genes {#s7}
=======================================================

The putative underlying mechanism of local over-connectivity and long-range over connectivity is supported by the following cognitive deficits:

-   Repetition of domain-specific routines in the absence of domain general executive integration; for e.g., echolalia but no functional spontaneous speech.

-   Deficit in long-range communication between parallel specialized sub-circuits, such as the amygdalae and fusiform face area, contributing to impaired emotion perception.

-   No cortical global workspace for integration of past and present experience.

-   Lack of learning by trial and error through social experience indicates domain general executive integration and generalizability.

Therefore, in autism, an initial domain specific deficit results in secondary lack of normal social experience. Dependence on local domain specific networks leads to cognitive rigidity. The link of modular deficit to mirror phenomena leads to repetitive behaviors in the absence of functional imitation.

Disturbed patterns of neuronal activity underlying specific types of behavior could be correlated with specific genetic alleles thus linking gene to brain development to behavior.

Conclusion {#s8}
==========

Learning is genetically programmed but environmental activity dependent. This bi-directional interface offers an opportunity for intervention. Through modeling, observational and imitation learning in the preschool years that enhance social -emotional and social-cognitive development can build stronger circuitry.

Genetically mediated deficits and consequent functional impairments involve activity-dependent synapse development, which depend on postnatal learning and experience. Understanding these neurobiological underpinnings can lead to the design of interventions that accommodate the way the brains of children with autism function and may lead to the promotion of more flexible thinking and learning. Furthermore, since genetically mediated deficits and consequent functional impairments involve activity-dependent synapse development that depends on postnatal learning and experience, early intervention can prevent or reduce the risk of these deficits cascading into a trajectory toward full expression of the disorder. Such a model implies the importance of intervening early to prevent downstream effects, and is supported by studies showing greater efficacy with early intervention programs which seek to counteract this early deficit and normalize the development of social and communicative capacities through provision of heavily enriched social stimuli by therapists and caregivers. This offers an opportunity to interrupt the sequence of events that would otherwise have resulted in an abnormal developmental trajectory, but instead promote interactions that normalizes basic brain responses to social stimuli and alter the course of development by exploiting the neuronal maturation and brain plasticity in the early years of life.
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